Algorithms Antirheumatic Agents Arthritis, Rheumatoid Article Biosimilar Pharmaceuticals Canada Clinical Competence Consensus Drug Substitution Group Processes Janus Kinase Inhibitors Janus kinase inhibitor Nocebo Effect Pharmacists Rheumatologists adalimumab algorithm biosimilar agent certolizumab pegol clinical competence clinical decision making consensus decision making disease activity drug safety etanercept expectation fatigue fecal microbiota transplantation follow up